Inhibition of agonist-induced hydrolysis of phosphatidylinositol and muscarinic receptor binding by the calcium antagonist 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate-HCl (TMB-8).
D000818:Animals; D002121:Calcium Channel Blockers / Q000494:pharmacology*; D002217:Carbachol / Q000037:antagonists & inhibitors; D002766:Cholecystokinin / Q000037:antagonists & inhibitors; D005707:Gallic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D006868:Hydrolysis; D066298:In Vitro Techniques; D051379:Mice; D010179:Pancreas / Q000378:metabolism; D010446:Peptide Fragments / Q000037:antagonists & inhibitors; D010716:Phosphatidylinositols / Q000378:metabolism*; D011950:Receptors, Cholinergic / Q000378:metabolism*; D011976:Receptors, Muscarinic / Q000187:drug effects / Q000378:metabolism*; D012844:Sincalide; D013363:Submandibular Gland / Q000378:metabolism
D002121:Calcium Channel Blockers; D010446:Peptide Fragments; D010716:Phosphatidylinositols; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; C006014:8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate; D005707:Gallic Acid; D002217:Carbachol; D002766:Cholecystokinin; D012844:Sincalide